Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients

Launched by NAZMY EDWARD SEIF · Mar 11, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how well a technique called lung ultrasound can help improve breathing in patients undergoing robotic surgery for prostate or bladder cancer. The goal is to find the best way to adjust a breathing support method known as Positive End Expiratory Pressure (PEEP) during surgery, which can help prevent lung problems after the operation. Using lung ultrasound is a quick and cost-effective approach that may lead to better oxygen levels and fewer breathing complications without causing issues with blood pressure.

To participate in this study, patients should be between the ages of 65 and 75, have normal or mild respiratory conditions, and be classified as ASA I, II, or III (which indicates different levels of health before surgery). However, those with severe obesity or significant lung or heart issues are not eligible. Participants can expect to receive personalized care during their surgery, including adjustments to their breathing support based on ultrasound findings. This trial is currently seeking volunteers, and it's an exciting opportunity to contribute to improving surgical care for patients with prostate and bladder cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ASA I, II \& III.
• • Normal respiratory functions or mild lung disease.
• Exclusion Criteria:
• • BMI more than 40.
• • Moderate to severe obstructive pulmonary disease (FEV1 \< 80% of predicted).
• • Moderate to severe restrictive pulmonary disease (TLC \< 70% of predicted).
• • Severe pulmonary hypertension (mean PAP\>55).
• • Previous lung surgery.
• • Decompensated cardiac disease (NYHA 3 or 4).
• • Patients who received invasive mechanical ventilation within the last 30 days before surgery.